Article info
PDFOriginal research
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study
- Correspondence to:
Professor A Briggs
Public Health and Health Policy, University of Glasgow, Glasgow G12 8RZ, UK; a.briggs{at}clinmed.gla.ac.uk
Citation
Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study
Publication history
- Accepted September 26, 2006
- First published November 29, 2006.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by Heart